The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial

Elke, GunnarGunnarElkeBloos, FrankFrankBloosWilson, Darius CameronDarius CameronWilsonBrunkhorst, Frank MartinFrank MartinBrunkhorstBriegel, JosefJosefBriegelReinhart, KonradKonradReinhartLoeffler, MarkusMarkusLoefflerKluge, StefanStefanKlugeNierhaus, AxelAxelNierhausJaschinski, UlrichUlrichJaschinskiMoerer, OnnenOnnenMoererWeyland, AndreasAndreasWeylandMeybohm, PatrickPatrickMeybohm2020-12-102020-12-102018https://resolver.sub.uni-goettingen.de/purl?gro-2/77529enCC BY 4.0https://creativecommons.org/licenses/by/4.0The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trialjournal_article10.1186/s13054-018-2001-5The Author(s).1364-8535https://resolver.sub.uni-goettingen.de/purl?gs-1/15166